Extracellular vesicle-associated repetitive element DNAs as candidate osteosarcoma biomarkers

Sci Rep. 2021 Jan 8;11(1):94. doi: 10.1038/s41598-020-77398-z.

Abstract

Osteosarcoma (OS) is the most common malignant bone tumor in children and young adults. Despite that high-risk factors have been identified, no test for early detection is available. This study aimed to identify circulating nucleic acid sequences associated with serum extracellular vesicle (EV) preparations at the time of OS diagnosis, as a step towards an OS early detection assay. Sequencing of small nucleic acids extracted from serum EV preparations revealed increased representation of diverse repetitive element sequences in OS patient versus control sera. Analysis of a validation cohort using qPCR of PEG-precipitated EV preparations revealed the over-representation of HSATI, HSATII, LINE1-P1, and Charlie 3 at the DNA but not RNA level, with receiver operating characteristic (ROC) area under the curve (AUC) ≥ 0.90. HSATI and HSATII DNAs co-purified with EVs prepared by precipitation and size exclusion chromatography but not by exosome immunocapture, indicative of packaging in a non-exosomal complex. The consistent over-representation of EV-associated repetitive element DNA sequences suggests their potential utility as biomarkers for OS and perhaps other cancers.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Biomarkers / metabolism*
  • Bone Neoplasms / diagnosis
  • Bone Neoplasms / genetics
  • Bone Neoplasms / metabolism*
  • Child
  • Child, Preschool
  • DNA / genetics
  • DNA / metabolism*
  • Extracellular Vesicles / genetics
  • Extracellular Vesicles / metabolism*
  • Female
  • Humans
  • Male
  • Osteosarcoma / diagnosis
  • Osteosarcoma / genetics
  • Osteosarcoma / metabolism*
  • Repetitive Sequences, Nucleic Acid
  • Young Adult

Substances

  • Biomarkers
  • DNA